Wegmans Recalls Cheese Products Over Listeria Risk
By I. Edwards HealthDay Reporter

THURSDAY, Aug. 14, 2025 — Wegmans is recalling several cheese products, including its medium camembert, because they may be contaminated with listeria, which can cause serious illness.
The U.S. Food and Drug Administration (FDA) issued the alert Wednesday. The recalled products were sold between July 1 and Aug. 12 at Wegmans locations in Connecticut, Delaware, Maryland, Massachusetts, New Jersey, New York, North Carolina, Pennsylvania, Virginia and Washington, D.C.
The recalled items include:
Wegmans Medium Camembert Soft Ripened Cheese, 8.8 oz.
UPC: 77890-53515
Best-by dates: 7/26/25, 8/12/25, 8/19/25
Wegmans Assorted Cheese Flight, 1 lb.
UPC: 2-77100-00000-0
Wegmans Grilling Camembert with Tapenade & Roasted Tomatoes, 10 oz.
UPC: 2-77297-00000-0
Wegmans Caramel Apple Pecan Topped Brie Cheese, 13 oz.
UPC: 2-77645-00000-3
So far, no illnesses have been reported to Wegmans or its supplier, but the FDA urges customers not to eat the recalled products. They can be returned to any Wegmans store for a full refund.
Listeria is a bacteria that can cause serious illness. The FDA says symptoms of infection can include high fever, headache, muscle aches, nausea, diarrhea, stiffness and more.
Pregnant people, newborns, older adults and those with weak immune systems are most at risk. In serious cases, listeria can lead to death.
If you have eaten one of the recalled products and develop symptoms, the FDA advises contacting your doctor right away.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-15 00:00
Read more

- WHO, UNICEF Say More Than 14 Million Infants Worldwide Remain Unvaccinated
- Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
- Americans Braced For Loss Of Gender-Affirming Care
- Veterans' Study Points to Better Treatment for Binge Eating Disorder
- Physicians Exiting Traditional Medicare Accelerated From 2010 to 2023
- Dizzy, Heart Racing After You Stand? New Treatment Proposed
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions